Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.040 Biomarker phenotype BEFREE We conclude that human hPSF-binding RNAs drive transformation and tumorigenesis by reversing PSF-mediated repression of proto-oncogene transcription and that dysfunctional regulation of human hPSF-binding RNA expression has a central role in the etiology of human cancer. 19625619 2009
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 AlteredExpression group BEFREE We conclude that human hPSF-binding RNAs drive transformation and tumorigenesis by reversing PSF-mediated repression of proto-oncogene transcription and that dysfunctional regulation of human hPSF-binding RNA expression has a central role in the etiology of human cancer. 19625619 2009
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 Biomarker group BEFREE Thus, Hakai can affect the oncogenic phenotype both by altering E-cadherin-based intercellular adhesions and by increasing PSF's ability to bind RNAs that promote cancer-related gene expression. 19855157 2009
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.040 AlteredExpression group BEFREE We propose that PSF protein and PSF-binding RNAs have a central role in the reversible regulation of mammalian cell proliferation and tumorigenesis and that increasing PSF expression or decreasing PSF-binding RNA expression in tumor cells is a potential therapeutic strategy for cancer. 19805375 2009
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.040 Biomarker phenotype BEFREE Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: effects on steroidogenesis and oncogenesis. 14704271 2004
CUI: C0007134
Disease: Renal Cell Carcinoma
Renal Cell Carcinoma
0.040 AlteredExpression disease BEFREE In papillary renal cell carcinomas the TFE3 transcription factor becomes fused to the PSF and NonO pre-mRNA splicing factors and most commonly to a protein of unknown function designated PRCC. 11313942 2001
CUI: C0007134
Disease: Renal Cell Carcinoma
Renal Cell Carcinoma
0.040 GeneticVariation disease BEFREE We demonstrate that the cytogenetically defined translocation t(X;1)(p11.2;p34) observed in papillary renal cell carcinomas results in the fusion of the splicing factor gene PSF located at 1p34 to the TFE3 helix-loop-helix transcription factor gene at Xp11.2. 9393982 1997
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.020 Biomarker group BEFREE As such, PSF must figure in both public health policy and stroke prevention programs, similar to other established metabolic and environmental factors. 31130312 2019
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.020 Biomarker group BEFREE Therapists working with stroke survivors conceptualise and manage PSF in different ways. 31826895 2019
Conventional (Clear Cell) Renal Cell Carcinoma
0.020 GeneticVariation disease BEFREE Xp11 translocation renal cell carcinoma (RCC) with SFPQ/PSF-TFE3 gene fusion is a rare epithelial tumor. 28315422 2017
MiT family translocation renal cell carcinoma
0.020 GeneticVariation disease BEFREE Xp11 translocation renal cell carcinoma (RCC) with SFPQ/PSF-TFE3 gene fusion is a rare epithelial tumor. 28315422 2017
MiT family translocation renal cell carcinoma
0.020 GeneticVariation disease BEFREE Xp11.2 translocation renal cell carcinoma with PSF-TFE3 rearrangement. 23628822 2013
Conventional (Clear Cell) Renal Cell Carcinoma
0.020 Biomarker disease BEFREE Secondary PSF/TFE3-associated renal cell carcinoma in a child treated for genitourinary rhabdomyosarcoma. 21504709 2011
CUI: C0007789
Disease: Cerebral Palsy
Cerebral Palsy
0.010 AlteredExpression disease BEFREE A total of 157 patients with nonambulatory CP (Gross Motor Function Classification System IV and V) with a minimum of 2-year follow-up after PSF were identified from a prospective multicenter registry. 31306277 2020
CUI: C0001144
Disease: Acne Vulgaris
Acne Vulgaris
0.010 Biomarker disease BEFREE Here, we fabricated the polysulfone microtube array membranes (PSF MTAM) to encapsulate probiotic <i>S.</i><i>epidermidis.</i> We demonstrate that the application of the encapsulation of <i>S.</i><i>epidermidis</i> in PSF MTAM enhanced the glycerol fermentation activities of <i>S. epidermidis.</i> To mimic the granulomatous type of acne inflammatory acne vulgaris, the ears of mice were injected intradermally with <i>C</i><i>.</i><i>acnes</i> to induce the secretion of macrophage inflammatory protein-2 (MIP-2), a murine counterpart of human interleukin (IL)-8. 30577530 2018
CUI: C0022821
Disease: Kyphosis deformity of spine
Kyphosis deformity of spine
0.010 AlteredExpression phenotype BEFREE A larger LL was obtained with a higher incidence of proximal junctional kyphosis at long-term follow-up after PSF. 30030189 2018
CUI: C0039585
Disease: Androgen-Insensitivity Syndrome
Androgen-Insensitivity Syndrome
0.010 GeneticVariation disease BEFREE We included 77 patients with Lenke 5 AIS who underwent ASF (n = 40) with a single rod with structural cages or PSF (n = 37) with pedicle screw instrumentation. 30030189 2018
CUI: C0265673
Disease: Congenital kyphosis
Congenital kyphosis
0.010 AlteredExpression disease BEFREE A larger LL was obtained with a higher incidence of proximal junctional kyphosis at long-term follow-up after PSF. 30030189 2018
CUI: C0410702
Disease: Adolescent idiopathic scoliosis
Adolescent idiopathic scoliosis
0.010 Biomarker disease BEFREE To compare the clinical and radiographic outcomes on the sagittal plane between anterior and posterior selective fusion (ASF and PSF) in patients with Lenke 5 adolescent idiopathic scoliosis (AIS) for a minimum of 5 years of follow-up. 30030189 2018
CUI: C0702166
Disease: Acne
Acne
0.010 Biomarker disease BEFREE Here, we fabricated the polysulfone microtube array membranes (PSF MTAM) to encapsulate probiotic <i>S.</i><i>epidermidis.</i> We demonstrate that the application of the encapsulation of <i>S.</i><i>epidermidis</i> in PSF MTAM enhanced the glycerol fermentation activities of <i>S. epidermidis.</i> To mimic the granulomatous type of acne inflammatory acne vulgaris, the ears of mice were injected intradermally with <i>C</i><i>.</i><i>acnes</i> to induce the secretion of macrophage inflammatory protein-2 (MIP-2), a murine counterpart of human interleukin (IL)-8. 30577530 2018
CUI: C1184923
Disease: Lumbar hyperlordosis
Lumbar hyperlordosis
0.010 Biomarker disease BEFREE A larger LL was obtained with a higher incidence of proximal junctional kyphosis at long-term follow-up after PSF. 30030189 2018
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.010 Biomarker group BEFREE High-resolution breast PET acquisitions, applying both small-voxel matrix and PSF modelling, appeared to improve the characterisation of breast tumours. 30594961 2018
CUI: C1998083
Disease: Inflammatory acne
Inflammatory acne
0.010 Biomarker disease BEFREE Here, we fabricated the polysulfone microtube array membranes (PSF MTAM) to encapsulate probiotic <i>S.</i><i>epidermidis.</i> We demonstrate that the application of the encapsulation of <i>S.</i><i>epidermidis</i> in PSF MTAM enhanced the glycerol fermentation activities of <i>S. epidermidis.</i> To mimic the granulomatous type of acne inflammatory acne vulgaris, the ears of mice were injected intradermally with <i>C</i><i>.</i><i>acnes</i> to induce the secretion of macrophage inflammatory protein-2 (MIP-2), a murine counterpart of human interleukin (IL)-8. 30577530 2018
CUI: C0004106
Disease: Astigmatism
Astigmatism
0.010 Biomarker disease BEFREE Astigmatism has a significant influence on the higher-order aberrations, MTF, and PSF in the children. 28656103 2017
CUI: C0015672
Disease: Fatigue
Fatigue
0.010 Biomarker phenotype BEFREE The correlation analysis shown at this component differs from cognitive and physical fatigue and describes another aspect of PSF, important in future treatment and research. 27267094 2017